
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
LOK CRISPR/Cas9 KO Plasmid (h) | sc-405859 | 20 µg | $397.00 |
Serine/threonine-protein kinase 10 (STK10), also known as lymphocyte-oriented kinase (LOK), is a STE20-family kinase that regulates cytoskeletal organization and cell polarity through phosphorylation events that influence actin dynamics and ERM (ezrin–radixin–moesin) protein function. In immune cells, LOK contributes to lymphocyte adhesion, migration, and immunological synapse architecture, linking receptor signaling to cortical actin remodeling. STK10 activity interfaces with Rho-family GTPase–dependent pathways and broader signaling networks that coordinate motility and tissue trafficking. Dysregulated cytoskeletal signaling and aberrant kinase-mediated control of cell movement have been associated with immune dysfunction and cancer-related phenotypes, making STK10 a relevant target for mechanistic studies.
LOK CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the STK10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the STK10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the STK10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish LOK protein expression.
This CRISPR knockout system enables efficient generation of STK10-deficient cell models for investigation of LOK signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.